Report cover image

Global Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Feb 11, 2025
Length 194 Pages
SKU # APRC19856932

Description

Summary

This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.

An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.

According to APO Research, The global Stable Isotope Labeled Biomolecules market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Stable Isotope Labeled Biomolecules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Stable Isotope Labeled Biomolecules, also provides the sales of main regions and countries. Of the upcoming market potential for Stable Isotope Labeled Biomolecules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stable Isotope Labeled Biomolecules sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Stable Isotope Labeled Biomolecules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Stable Isotope Labeled Biomolecules sales, projected growth trends, production technology, application and end-user industry.


Stable Isotope Labeled Biomolecules Segment by Company

Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes

Stable Isotope Labeled Biomolecules Segment by Type

D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
Others

Stable Isotope Labeled Biomolecules Segment by Application

Scientific Research
Medical
Industrial
Others

Stable Isotope Labeled Biomolecules Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stable Isotope Labeled Biomolecules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Stable Isotope Labeled Biomolecules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Stable Isotope Labeled Biomolecules Market Size, 2020 VS 2024 VS 2031
1.3 Global Stable Isotope Labeled Biomolecules Market Size Estimates and Forecasts (2020-2031)
1.4 Global Stable Isotope Labeled Biomolecules Sales Estimates and Forecasts (2020-2031)
1.5 Global Stable Isotope Labeled Biomolecules Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Stable Isotope Labeled Biomolecules Market Dynamics
2.1 Stable Isotope Labeled Biomolecules Industry Trends
2.2 Stable Isotope Labeled Biomolecules Industry Drivers
2.3 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
2.4 Stable Isotope Labeled Biomolecules Industry Restraints
3 Stable Isotope Labeled Biomolecules Market by Manufacturers
3.1 Global Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2020-2025)
3.2 Global Stable Isotope Labeled Biomolecules Sales by Manufacturers (2020-2025)
3.3 Global Stable Isotope Labeled Biomolecules Average Sales Price by Manufacturers (2020-2025)
3.4 Global Stable Isotope Labeled Biomolecules Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application
3.7 Global Stable Isotope Labeled Biomolecules Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Stable Isotope Labeled Biomolecules Market CR5 and HHI
3.8.2 Global Top 5 and 10 Stable Isotope Labeled Biomolecules Players Market Share by Revenue in 2024
3.8.3 2024 Stable Isotope Labeled Biomolecules Tier 1, Tier 2, and Tier 3
4 Stable Isotope Labeled Biomolecules Market by Type
4.1 Stable Isotope Labeled Biomolecules Type Introduction
4.1.1 D Labeled Biomolecules
4.1.2 15N Labeled Biomolecules
4.1.3 13C Labeled Biomolecules
4.1.4 Others
4.2 Global Stable Isotope Labeled Biomolecules Sales by Type
4.2.1 Global Stable Isotope Labeled Biomolecules Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Stable Isotope Labeled Biomolecules Sales by Type (2020-2031)
4.2.3 Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2020-2031)
4.3 Global Stable Isotope Labeled Biomolecules Revenue by Type
4.3.1 Global Stable Isotope Labeled Biomolecules Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Stable Isotope Labeled Biomolecules Revenue by Type (2020-2031)
4.3.3 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2020-2031)
5 Stable Isotope Labeled Biomolecules Market by Application
5.1 Stable Isotope Labeled Biomolecules Application Introduction
5.1.1 Scientific Research
5.1.2 Medical
5.1.3 Industrial
5.1.4 Others
5.2 Global Stable Isotope Labeled Biomolecules Sales by Application
5.2.1 Global Stable Isotope Labeled Biomolecules Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Stable Isotope Labeled Biomolecules Sales by Application (2020-2031)
5.2.3 Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2020-2031)
5.3 Global Stable Isotope Labeled Biomolecules Revenue by Application
5.3.1 Global Stable Isotope Labeled Biomolecules Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Stable Isotope Labeled Biomolecules Revenue by Application (2020-2031)
5.3.3 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2020-2031)
6 Global Stable Isotope Labeled Biomolecules Sales by Region
6.1 Global Stable Isotope Labeled Biomolecules Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Stable Isotope Labeled Biomolecules Sales by Region (2020-2031)
6.2.1 Global Stable Isotope Labeled Biomolecules Sales by Region (2020-2025)
6.2.2 Global Stable Isotope Labeled Biomolecules Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Stable Isotope Labeled Biomolecules Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Stable Isotope Labeled Biomolecules Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Stable Isotope Labeled Biomolecules Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Stable Isotope Labeled Biomolecules Revenue by Region
7.1 Global Stable Isotope Labeled Biomolecules Revenue by Region
7.1.1 Global Stable Isotope Labeled Biomolecules Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Stable Isotope Labeled Biomolecules Revenue by Region (2020-2025)
7.1.3 Global Stable Isotope Labeled Biomolecules Revenue by Region (2026-2031)
7.1.4 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Stable Isotope Labeled Biomolecules Revenue (2020-2031)
7.2.2 North America Stable Isotope Labeled Biomolecules Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Stable Isotope Labeled Biomolecules Revenue (2020-2031)
7.3.2 Europe Stable Isotope Labeled Biomolecules Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Stable Isotope Labeled Biomolecules Revenue (2020-2031)
7.4.2 Asia-Pacific Stable Isotope Labeled Biomolecules Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Cambridge Isotope Laboratories
8.1.1 Cambridge Isotope Laboratories Comapny Information
8.1.2 Cambridge Isotope Laboratories Business Overview
8.1.3 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Product Portfolio
8.1.5 Cambridge Isotope Laboratories Recent Developments
8.2 Sigma-Aldrich
8.2.1 Sigma-Aldrich Comapny Information
8.2.2 Sigma-Aldrich Business Overview
8.2.3 Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sigma-Aldrich Stable Isotope Labeled Biomolecules Product Portfolio
8.2.5 Sigma-Aldrich Recent Developments
8.3 Thermo Fisher Scientific
8.3.1 Thermo Fisher Scientific Comapny Information
8.3.2 Thermo Fisher Scientific Business Overview
8.3.3 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Product Portfolio
8.3.5 Thermo Fisher Scientific Recent Developments
8.4 LGC Standards
8.4.1 LGC Standards Comapny Information
8.4.2 LGC Standards Business Overview
8.4.3 LGC Standards Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 LGC Standards Stable Isotope Labeled Biomolecules Product Portfolio
8.4.5 LGC Standards Recent Developments
8.5 Toronto Research Chemicals
8.5.1 Toronto Research Chemicals Comapny Information
8.5.2 Toronto Research Chemicals Business Overview
8.5.3 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Product Portfolio
8.5.5 Toronto Research Chemicals Recent Developments
8.6 IsoLife
8.6.1 IsoLife Comapny Information
8.6.2 IsoLife Business Overview
8.6.3 IsoLife Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 IsoLife Stable Isotope Labeled Biomolecules Product Portfolio
8.6.5 IsoLife Recent Developments
8.7 WITEGA Laboratorien
8.7.1 WITEGA Laboratorien Comapny Information
8.7.2 WITEGA Laboratorien Business Overview
8.7.3 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Product Portfolio
8.7.5 WITEGA Laboratorien Recent Developments
8.8 Omicron Biochemicals
8.8.1 Omicron Biochemicals Comapny Information
8.8.2 Omicron Biochemicals Business Overview
8.8.3 Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Omicron Biochemicals Stable Isotope Labeled Biomolecules Product Portfolio
8.8.5 Omicron Biochemicals Recent Developments
8.9 Icon Isotopes
8.9.1 Icon Isotopes Comapny Information
8.9.2 Icon Isotopes Business Overview
8.9.3 Icon Isotopes Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Icon Isotopes Stable Isotope Labeled Biomolecules Product Portfolio
8.9.5 Icon Isotopes Recent Developments
8.10 Medical Isotopes
8.10.1 Medical Isotopes Comapny Information
8.10.2 Medical Isotopes Business Overview
8.10.3 Medical Isotopes Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Medical Isotopes Stable Isotope Labeled Biomolecules Product Portfolio
8.10.5 Medical Isotopes Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Stable Isotope Labeled Biomolecules Value Chain Analysis
9.1.1 Stable Isotope Labeled Biomolecules Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Stable Isotope Labeled Biomolecules Production Mode & Process
9.2 Stable Isotope Labeled Biomolecules Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Stable Isotope Labeled Biomolecules Distributors
9.2.3 Stable Isotope Labeled Biomolecules Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.